Rabies Prevention and Treatment
Rabies Prevention and Treatment
Rabies Prevention and Treatment
❑ 2 options:-
Intradermal ARV 0.1ml single dose
Intramuscular ARV 1 dose on day-0, day-7 and day-28
Followed by a booster dose in 1 year and additional booster doses every 5 years.
❖ Single or multiple bites with bleeding on head, neck, face, chest, upper arms, palms, tips of
fingers & toes and genitalia
❖ Single or multiple deep bites with free flowing of blood on any part of the body
❖ Single or multiple deep scratches with free flowing of blood on the head, neck and face
❖ Drinking water from a well where an animal has fallen and died
❖ Bites from cold blooded animals (reptiles, amphibians) and pecks by birds
❖ PET for superficial scratches with bleeding, caused by healthy observable domestic animals
(irrespective of vaccination status of the animal) also could be delayed while observing the animal
for 14 days.
❖ If the animal becomes sick, develops any suspicious behavior, goes missing or dies, the patient
should be advised to report to the hospital immediately to commence PET.
If the animal is having suspicious behavior or sick but observable (irrespective of the vaccination
status) initiate PET while observing the animal. Discontinue PET if the animal is healthy after 14
days.
If the animal is having rabies (confirmed by laboratory diagnosis) or unobservable (stray animal,
animal dead, killed, missing; irrespective of the vaccination status) initiate PET and continue the
full course .
PET for minor exposures: only anti rabies vaccine is indicated even if the animal is proven to be
rabid.
Management of a patient with a major exposure
❑ If the animal is apparently healthy, observable with a reliable history and has documented proof of: -
❑ If the animal is apparently healthy, domestic and observable with a reliable history: -
Initiate PET immediately with rabies immunoglobulin (RIG) and follow with a full course of anti rabies
vaccine (ARV).
RABIES TREATMENT
❖ For all age groups, ID injection sites are the deltoid region, anterolateral thigh or suprascapular regions.
❖ It is recommended to use fixed needle 1ml disposable syringes for intradermal administration of ARV to
minimize vaccine wastage.
Intradermal (ID) schedules of ARV
One dose each (0.1ml) is given at 2 sites, on both arms (over deltoids) on DO, D3, D7 and D30.
IM-ARV one dose* each on DO, D3, D7, D14, & D30
This schedule is recommended for patients who are immunocompromised and for international travelers.
2 doses * of IM-ARV one in each deltoid on DO, followed by 1 dose* each on D7 & D21.
*1 dose - PCEC 1ml (1 vial) / PVRV 0.5ml (1vial)
❖ IM injections should be given into the deltoid muscle or into the anterolateral aspect of the thigh in small
children.
❖ Administration of ARV on the buttocks is not recommended as absorption is poor
Management of patients following previous rabies PET
1. Patients presenting with exposures from healthy, observable domestic animals (irrespective of the vaccination status)
▪ Following a full or a partial course of ARV (3 doses of ID /IM ARV) irrespective of the time duration for both major and
minor exposures, PET could be delayed while observing the animal for 14 days.
▪ If the animal becomes sick, develops any suspicious behavior, goes missing or dies during the observation period, the
patient should be advised to report to the hospital immediately to commence PET
2. Patients presenting with exposures from proven rabid, suspicious, sick, dead or unobservable animals
With a documented evidence of a full course of ARV-
a) with an exposure occurring within 3 months, neither RIG nor ARV is needed. Only wound treatment is required.
b) with an exposure occurring after 3 months of the previous course of PET, irrespective of the time duration,
-RIG is not indicated
-ID ARV 2 doses each or IM ARV one dose each, should be given on DO and D3 as boosters. As an alternative to this, the
patient may be offered a single visit 4 site intradermal doses (0.1ml ID) over deltoids and suprascapular/anterolateral thigh
areas.
3. With a documented evidence of a partial course of ARV (3 doses)
a) RIG is not indicated irrespective of the time duration from the previous course of ARV.
b) If the patient presents with an exposure occurring within one month from the initiation of the course, it could
be completed with the D30 ARV dose.
c) If the patient presents within 10years - ID ARV 2 doses each or IM ARV one dose each should be given on DO
and D3 as boosters
d.) If the patient presents after 10years -ID/ IM ARV full course is recommended.
Important points to be noted
❖ Pregnancy/breast feeding is not a contraindication for RIG (ERIG/HRIG) and ARV therapy when indicated.
❖ All patients who receive rabies PET should be given a document/card, clearly stating the date, month & the year of
vaccination, the type of vaccine used and RIG given or not.
❖ In situations where the animal is not vaccinated, encourage the owner to vaccinate the animal concerned after the
observation period.
❖ Human to human transmission of rabies has not been reported (except through corneal or organ grafts)